Guidelines for the management of breakthrough pain in patients with cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 11, Issue SUPPL.1, 2013, Pages

  Caraceni, Augusto ^a,b   Davies, Andrew ^c   Poulain, Philippe ^d   Cortés Funes, Hernán ^e   Panchal, Sunil J ^f   Fanelli, Guido ^g  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c St Lukes Hospital   (United Kingdom)

^d Polyclinique de l'Ormeau   (France)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f National Institute of Pain   (United States)

^g UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; OPIATE;

ADVANCED CANCER; ARTICLE; BREAKTHROUGH PAIN; BREATHING RATE; CANCER PAIN; CANCER PATIENT; CLINICAL ASSESSMENT TOOL; DROWSINESS; DRUG DOSE TITRATION; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATIENT CARE; SEDATION; SELF REPORT; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 84875900414     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0211     Document Type: Article

References (39)

1. Cousins MJ, Lynch ME. The Declaration Montreal: access to pain management is a fundamental human right. Pain 2011;152: 2673-2674.
2. Turone F. Italy sets up palliative care service after MPs vote in new law. BMJ 2010; 340:c1481.
3. Loi no 99-477 du 9 juin 1999 visant à garantir le droit à l'accès aux soins palliatifs [Act No. 99-477 of 9 June 1999 to ensure the right of access to palliative care]. Available at: Legifrance.gouv.fr. Accessed December 19, 2012.
4. Chinellato A, Terrazzani G, Debetto P, et al. Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian region. Br J Clin Pharmacol 2006;62: 130-133.
5. Chinellato A, Skaper SD, Giusti P, et al. Consumption of opioid analgesics in Italy: light at the end of the tunnel? Eur J Pain 2011;15: 220-221.
6. European Association of Palliative Care. Bibliographic reports on the national development of palliative care in Europe. Available at: http://www.eapc-taskforce-development.eu/documents/national/eapc-france.pdf. 2012. Accessed September 17, 2012.
7. Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012;13:e58-68.
8. Knudsen AK, Aass N, Fainsinger R, et al. Classification of pain in cancer patients - a systematic literature review. Palliat Med 2009;23: 295-308.
9. Knudsen AK, Brunelli C, Klepstad P, et al. Which domains should be included in a cancer pain classification system? Analyses of longitudinal data. Pain 2012;153: 696-703.
10. Davies AN, Dickman A, Reid C, et al. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009;13: 331-338.
11. Haugen DF, Hjermstad MJ, Hagen N, et al. Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain 2010;149: 476-482.
12. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990;41: 273-281.
13. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999;81: 129-134.
14. Portenoy RK, Bruns D, Shoemaker B, et al. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics. J Opioid Manag 2010;6: 97-108.
15. Davies A, Zeppetella G, Andersen S, et al. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 2011;15: 756-763.
16. Caraceni A, Martini C, Zecca E, et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 2004;18: 177-183.
17. Portenoy RK, Bruns D, Shoemaker B, et al. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life. J Opioid Manag 2010;6: 109-116.
18. Abernethy AP, Wheeler JL, Fortner BV. A health economic model of breakthrough pain. Am J Manag Care 2008;14(5 Suppl 1):S129-140.
19. World Health Organization. Cancer pain relief and palliative care: report of a WHO Expert Committee. Geneva, Switzerland: World Health Organization; 1990.
20. Hanks GW, de Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001;84: 587-593.
21. Poulain P, Michenot N, Ammar D, et al. Mise au point sur l'utilisation du fentanyl transmuqueux: chez le patient présentant des douleurs d'origine cancéreuse. Douleurs 2012;13: 34-39.
22. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 1999;82: 263-274.
23. Caraceni A, Bertetto O, Labianca R, et al. Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI - Italian questionnaire for intense episodic pain. J Pain Symptom Manage 2012;43: 833-841.
24. Portenoy RK, Bennett DS, Rauck R, et al. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain 2006;7: 583-591.
25. Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 2003;101: 55-64.
26. Laverty D, Davies A. Assessment. In: Davies A, ed. Cancer-related Breakthrough Pain. New York, NY: Oxford University Press; 2006: 23-30.
27. Hagen NA, Stiles C, Nekolaichuk C, et al. The Alberta Breakthrough Pain Assessment Tool for cancer patients: a validation study using a Delphi process and patient think-aloud interviews. J Pain Symptom Manage 2008;35: 136-152.
28. Zeppetella G, Ribeiro MD. Episodic pain in patients with advanced cancer. Am J Hosp Palliat Care 2002;19: 267-276.
29. Davies AN. The management of breakthrough cancer pain. Br J Nurs 2011;20: 803-807.
30. Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev 2006;CD004311.
31. Hagen NA, Fisher K, Victorino C, et al. A titration strategy is needed to manage breakthrough cancer pain effectively: observations from data pooled from three clinical trials. J Palliat Med 2007;10: 47-55.
32. Pigni A, Brunelli C, Gibbins J, et al. Content development for EUROPEAN GUIDELINES on the use of opioids for cancer pain: a systematic review and Expert Consensus Study. Minerva Anestesiol 2010;76: 833-843.
33. Haute Autorité de Santé (HAS). Bon usage du médicament: les médicaments des accès douloureux paroxystiques du cancer [HAS Good use of medicine: cancer-related breakthrough pain relieving drugs]. Available at: http://www.has-sante.fr/portail/upload/ docs/application/pdf/2011-09/acces-douloureux-paroxystiques-fiche- bum.pdf. Accessed December 19, 2012.
34. Consenso sobre dolor irruptivo oncologico. 2012. Available at: http://www.actasanitaria.com/fileset/doc-65005-FICHERO- NOTICIA-49088.pdf. Accessed January 18, 2013.
35. Virizuela JA, Escobar Y, Cassinello J, et al. Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice. Clin Transl Oncol 2012;14: 499-504.
36. Acta Sanitario. Consenso sobre dolor irruptivo oncolgico. Available at: http://www.actasanitaria.com/fileset/doc-65005- FICHERO-NOTICIA-49088.pdf. 2012. Accessed September 7, 2012.
37. Escobar Álvarez Y. New approaches to the diagnosis and treatment of breakthrough cancer pain consensus document. Presentation at: XIV Simposio de Revisiones En Cancer; February 8-10, 2012; Madrid, Spain.
38. Swarm R, Abernethy AP, Anghelescu DL, et al. NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 2, 2012. Available at: www.NCCN.org. Accessed September 17, 2012.
39. Kaasa S, Apolone G, Klepstad P, et al. Expert conference on cancer pain assessment and classification - the need for international consensus: working proposals on international standards. BMJ Support Palliat Care 2012;1: 281-287.